Realist
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No company is going to acquire INND. There can be an ASSET SALE which means INND will be selling the business to someone, but that is unlikely due to balance sheet and they are losing $1.4 million on $2.3 million in sales. The business model does not work.
They are better off filing bankruptcy to try to keep the business running, take it out of INND and then sell INND for a reverse merger.
Anything other than that type of a plan is meaningless and a waste of time, money and energy.
Matt and his parents have no clue what it takes to be a public company and the toxic financings that they've done over the years shows they are inept and can not be trusted with shareholder money. Not to mention they NEVER attracted a single fund manager in all the years they've been a public company.
It would not be a hostile takeover. Spirit shareholders do not want to acquire another company and Spirit's balance sheet does not provide an opportunity for an acquisition to happen. Spirit management knows they can not support an acquisition of any type and raising capital would be a moot point.
As for Jet Blue being delisted or moved to OTC, it will not happen because they can do a reverse stock spilt. Jet Blue has an intrinsic value and a book value that exceeds the current market cap.
Not to mention that Blackrock bought over 9 million shares over the 3 month period ending June 2023, as well as other very large investment firms acquiring the stock on the open market.
To be fair Wellington has sold a substantial amount of stock for the quarter ended June 2023, but the buying by other institutional investors has been far more than the selling.
This can be as simple as hitting the bod for the past 3 months
I am LONG JBLU and would like to see an increase in stock price, but I am curious why do you post BIG UPSIDE TODAY
What is your thesis behind the statement, or are you just hopeful the stock will go up. I am trying to understand what you are posting or if its hyperbole
Well the big news came out yesterday - they are considering going private.
That is big news - management doesn't give investors any hope that the stock will go up.
No wonder the stock is down, even management doesn't believe in the stock.
Truth be told, for management to issue that press release is a terrible public relations move because he is basically telling any potential new investor that investing in EFSH may result in you never being able to sell your shares because we may go private, It's a terrible PR move and it shows that management and board have no clue as to what they are doing or what it takes to be a public company.
BIG NEWS IS OUT - COMPANY IS GOING PRIVATE AND SHAREHOLDERS WILL BE SCREWED BECAUSE THEY WILL OWN STOCK IN AN ILLIQUID PRIVATE COMPANY.
BIG NEWS
That did not take long to go under $1.00 a share.
How quick can do a reverse split, or buy 1,000 shares on the open market to get the price up: 100 shares at $1.10, then 100 shares at $1.20, then 100 shares at $1.30 - get it to $2.00 in 100 lot increments to make the company look more appealing to investors.
People will think it is worth $2.00 a share, but that would be called manipulation and anyone that thinks they can sell the stock at $2.00 would be wrong!
Good Luck to All, and to All a Good Night
A public company WORTH is determined by the market cap. The stock price determines the WORTH, but only when calculated on a fully diluted basis.
In other words, a company with a $5.00 stock price can be WORTH $10 Billion, and can acquire a company that has a $25.00 stock price if the WORTH is only $5 Billion.
Jet Blue is worth $1.6 Billion
Spirit is worth $1.7 Billion
These numbers are based on today's closing stock price.
Spirit has been valued (WORTH) in the $1.7 Billion range for last few months.
Jet Blue was valued (WORTH) in the $3.2 Billion range just 2-months ago.
The recent decline has been bad for Jet Blue and therefore not sure how and if that will impact the acquisition/merger.
why bullish
Short position taken
EFSH will be under $1.00 within 2-weeks due to their toxic financing and management really not knowing how to sell themselves to the market. They think issuing press releases about revenues and profits is the way to go is plain old wrong. They need to have quarterly conference calls, analyst meetings, presentations at conferences. Not sure that they are doing, but I can say they are not bringing in good money through their financings and they have a lack of demand for the supply in their stock.
Is the buy rating independent
or did the company pay for a research report
if the buy rating by a bank doing a banking deal or any sort of conflict
If you, the FBI or the company attorney need clarity, let me be clear:
I think BSEG is a bad investment for many reasons
I think the stock will do poorly
I do not see how they will raise capital through a S3
I hope, predict look for a reverse split, because I will SHORT the stock.
If there is anything in my wording that you or someone else thinks needs legal or department of justice investigation, roll the dice because I love to SHORT stocks and I do not hide behind that.
There is a reason hedge fund managers make the amount of money they do, and it is because more company stocks go down yearly than go up.
Easier to predict a failing company, than a successful company.
I will leave you with these 2 words ........
Good Luck
I wish you the best of luck in your investment. It would appear as of you did more homework than me and you will reap the rewards.
Good Luck, as I am sure you don't need my words of encouragement.
Truth is I am predicting a reverse split and once that happens the stock will most likely go down.
I look for companies that do reverse splits because those stock go down 100% of the time.
I am hoping for that in BSEG
I don't say your misinformed or promotional for your position in BSEG.
Name calling me or putting tags on me is childish.
My opinion on BSEG is what it is.
Your opinion is what it is.
One of us will make money or not lose money, while one will lose money
Let us see what happens
Investing is about making decisions quickly.
Successful investing (ie, making a profit) is about predicting things before they happen.
Last month they pre recorded the emerging growth conference presentation, which I think is a bad decision.
The press release they issued about today's presentation stated the same thing - a pre recording.
Then a S3 announcement. who in their right mind would invest in that?
if I am right, and they get no one to invest, the stock will go down because the only other way they will get capital is to do some form of toxic financing which will drive the stock to 0001.
Putting that aside, this management team is inept, so that means even if they did raise money through the S3, the stock will go down because they are looking to raise $500,000. Forst and foremost $500K is nothing and that is probably going to be used to pay their salaries or repay expenses. And even if they didn't use the money to repay salaries, what is $500K when it comes to film production?
What a joke.
I posted during the presentation.
I do short stocks and always look for inept management teams, balance sheets that have toxic financings and businesses that make no sense to me.
It is an embarrassment - they don't give a live presentation. They give a pre-recorded presentation.
They make no money
They lose money every year
They are talking about a Reg D offering which makes no sense.
They have no institutional ownership
They don't have an investment banking firm
The CEO surrounds herself with people that sound and look like they have no business experience.
If this company raises $500,000 I will lose all hope in humanity.
I do not know where the stock will be 1-month from now, none the less 6-months from now, but the balance sheet, cash flow and pro forma earnings per share tell me that $6.00 a share is undervalued.
I am not thinking $10 or any price right now, I am just hopeful the sell-side is out. What I really mean is that I hope all the current shareholders that wanted to sell are out, and I hope that the shorts had to cover so they are out (and made their money) so now LONG investors can come in and make money on JBLU.
If I am wrong, it wont be the first time I am wrong, but it doesn't happen that often.
you are lying
i looked at all the trades and it is impossible for your trades to have occurred
you are 100% lying
i hate when people try to claim a victory AFTER THE FACT.
you are weak, you ly and you probably lie so much you believe yourself
I am eager for Sept 11 - as soon as the reverse stock split is done I am going to short this stock because it will go down so much so quick. I can only hope I get my short trade execution in as quickly as possible.
The stock is up 2 cents and some people think that is great ?????
The stock is at 12 cents down from $3.00 less than a year ago !!!!!
Management issued a press release saying that they restructured the promissory notes - I hope you all understand that the new terms may be worse than the current terms, which were terrible!!!!!
I am in AWE that some people are happy and think the stock will go up, and it makes me laugh when I see a stock go up 2 cents and people are thrilled and think its the beginning of a run.
I feel sorry for so many on this board and I am going to have to stop posting here because the only people that made money are the ones that shorted EFSH and know that this stock is heading to 0001
Good Luck and I feel pity on many of you
The summer season has been predominantly good for all airlines so as long as JBLU doesn't have massive expenses or unforeseen costs associated with respect to software and computer updates and hardware then I expect the next 10Q to be good, but that alone will not drive the stock price up. I think new routes and somehow getting away from all the price wars with other airlines will be the driving force for stock.
I also think a merger or some form of acquisition with a regional international carrier is something that JBLU needs in its quest to be considered one of the true major carriers on an international level
The Spirit deal has and will create headaches and that is why I think some other type of M&A is necessary. Truth is I am not a fan of the Spirit deal, unless JBLU believes Spirit has that many loyal customers and those customers will use JBLU for routes that Spirit does not fly. But that is something only JBLU and Spirit management know because they have all the data on customers.
But it better be good for cross-selling to the other airline customers post closing of the deal.
$2 Billion market cap does seem quite low for their revenues, assets, cash flow and future expectations.
EFSH hires Shareholder Intelligence Services many months ago to look into illegal stock trading.
On August 14 they issue a press release about their ongoing efforts into illegal stock trading.
On August 25 they issue a press release regarding dilutive conversion of warrants that they actually admit will be detrimental to the stock. Keep in mind they signed and entered into a deal with the warrants.
Which one is - is it illegal trading or bad management that signed and entered into toxic capital raises.
On November 28, 2022 I issued a post on this message board that EFSH was a bad investment. That was when the stock was $2.75 a share.
About a month ago I posted that EFSH was a bad investment when the stock was 20 cents.
At 11 cents it is still a bad investment in my opinion because they entered into a prior deal with Mast Hill and based on the deal terms EFSH is probably heading to 0001 a share.
So EFSH management issuing a press release about illegal trading and then issuing a press release that dilutive warrants will be detrimental to the stock price is contradictory and shows management has no idea on what it takes for a public company to get stock price increase.
My OPINION about Endonovo - the company has never had sales.
My OPINION about ENDV stock - the stock has never increased, in fact it has a history from the day that Alan Collier took over as CEO that the stock has been in a rapid decline and the only reason they are not on the pink sheets or revoked by the SEC is because they continue to do reverse splits.
MY OPINION about Sofpulse - The product is a failure, or simply doesn't work. This opinion is based on Ivivi trying to make a go of it and failed and the fact that Alan Collier has announced numerous distribution deals with many different companies and a few years ago he even hired in-house sales people, neither has produced any sales.
My OPINION on the future - Alan Collier will continue to try to run the business and get loans or convertible notes because that brings in cash so he can pay himself a salary and receive health benefits for himself and his family. This process is actually legal, but only successful if people buy the stock on the open market because the convertible note holders only make money if there is trading in the stock because they get the stock at a big discount to market and when they get the stock they sell it, because investors buy the stock on the open market and inevitably lose money.
My OPINION about anyone being positive on this message board about the company or stock - People that are paid for a service are biased, and therefore have no worth or legitimacy when it comes to discussing their opinions and suggestions when it comes to stock price, market cap or anything related to buying, selling or holding a stock that they are being paid to support, promote or encourage others to buy.
I don't know who bought the 306,000 shares that were traded so far today, but it only means $3,600 dollars worth of stock traded. It's very disappointing that some people do not understand investing because ENDV is not a good investment.
This is my last post on this message board because its disheartening to see people lose money to what is a legal scam like convertible notes and toxic financings that Alan Collier has done through Endonovo. It's LEGAL, but a shame.
On August 8th Endonovo issued a press release and had this line included in the press release:
The Company has made significant strides in multiple areas of sales, marketing, branding, management and financing. These milestones give management confidence for sustained growth and substantial revenues. The Company is focusing on its FDA Cleared Pulsed Electro Magnetic Field (PEMF) technologies and the telehealth industries.
Significant strides in sales. That means they will be announcing sales, like lots of revenues.
They used the word SIGNIFICANT.
If they increased sales significantly, then I applaud them.
If they didn't increase sales then Alan Collier is either a stupid human being, terrible CEO or just issues fluff press releases to try to get people to buy the stock so he doesn't get booted off of the OTCQB.
They issued the press release on August 8, which is over a month AFTER THE QUARTER ENDED so he knew what the sales were at the time he issued the press release so lets see what type of a person Alan Collier is.
The company issues a press release this week talking about some inappropriate stock trading which I guess they are blaming on the stock price decline.
What about this disclosure that they made recently, ANY CHANCE THAT IS THE REASON THE STOCK WENT DOWN
Item 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.
As previously disclosed, on February 3, 2023, 1847 Holdings LLC (the “Company”) issued a promissory note in the principal amount of $104,000 to Mast Hill Fund, L.P. (“Mast Hill”) and a promissory note in the principal amount of $500,000 to Leonite Fund I, LP (“Leonite”). These promissory notes (the “February 3 Notes”) are convertible into the Company’s common shares only upon an Event of Default (as defined in the February 3 Notes).
On August 4, 2023, the Company received notices (the “August 4 Notices”) from Mast Hill and Leonite that an Event of Default has occurred under the February 3 Notes for failure to make certain payments when due. Notwithstanding the foregoing, Mast Hill and Leonite agreed that they will not require any payments in cash for the over-due amounts or accelerate the payments due under the February 3 Notes for a period of 60 days. Since an Event of Default has occurred, Mast Hill and Leonite have the right to convert the February 3 Notes, including the over-due amounts, into common shares at their election.
As previously disclosed, on February 9, 2023, the Company issued a promissory note in the principal amount of $1,390,909 to Mast Hill and a promissory note in the principal amount of $1,166,667 to Leonite. These promissory notes (the “February 9 Notes”) are convertible into the Company’s common shares only upon an Event of Default (as defined in the February 9 Notes).
On August 9, 2023, the Company received notices (the “August 9 Notices”) from Mast Hill and Leonite that an Event of Default has occurred under the February 9 Notes for failure to make certain payments when due. Notwithstanding the foregoing, Mast Hill and Leonite agreed that they will not require any payments in cash for the over-due amounts or accelerate the payments due under the February 9 Notes for a period of 60 days. Since an Event of Default has occurred, Mast Hill and Leonite have the right to convert the February 9 Notes, including the over-due amounts, into common shares at their election.
As previously disclosed, on February 22, 2023, the Company issued a promissory note in the principal amount of $878,000 to Mast Hill (the “February 22 Note”). The February 22 Note is convertible into the Company’s common shares only upon an Event of Default (as defined in the February 22 Note).
On August 10, 2023, the Company received a notice (the “August 10 Notice”) from Mast Hill that an Event of Default has occurred under the February 22 Note for failure to make certain payments when due. Notwithstanding the foregoing, Mast Hill agreed that it will not require any payments in cash for the over-due amounts or accelerate the payments due under the February 22 Note for a period of 60 days from August 9, 2023. Since an Event of Default has occurred, Mast Hill has the right to convert the February 22 Note, including the over-due amounts, into common shares at its election.
I guess Ellery Roberts wants to blame some type of manipulation, and just avoid discussing or noting the default that 1847 is facing.
I guess Ellery doesn't want to disclose the discount to market convertible notes that he has entered into.
It's easy to blame someone and everyone else, but the blame should be with Ellery and all his decisions because anyone with some knowledge of convertible notes knows that most public companies that enter into these types of convertible notes almost always end with a stock price decline.
I never manipulated EFSH stock, I just knew it was going to decline because of the balance sheet and convertible notes that they entered into with Mast Hill.
What a waste of EFSH time and money doing an investigation into stock manipulation. And even if he was right and there was stock manipulation, there is no recourse or anything that EFSH will get back.
Stock is down and that is all there is to it. TAKE RESPONSIBILITY FOR YOUR ACTIONS ie entering into toxic finance deals and not being able to pay off your debt.
November 28, 2022
my mistake
i make many clerical mistakes, but no mistakes with investments and investment decisions
Why would you buy the stock. They have toxic financings in place which drive stock price down, and when they raise capital it is at a steep discount to market.
Their deals and revenues are meaningless for the stock price.
In fact, the more revenues the more they grow and increase revenues the more they will need to raise capital to fulfill the purchase orders. Those capital raises will dilute the company further and the discount to market will drive stock price down.
This stock has no chance of ever increasing.
Nice run up in the stock price this year.
I do have a question that needs to be answered
In the press release is the following line: The Company has made significant strides in multiple areas of sales, marketing, branding, management and financing.
I did not see anywhere in the press release about any type of financing?
Just got into Jetblue over the last 2-weeks.
The run down in stock price does not reflect the fundamentals or true value of the stock. Based on institutional investors holdings it would seem as if some large funds sold the shares but that doesnt mean the sell off was due to JBLU, or maybe the funds had to sell.
Regardless, fundamentals look good and it's time to take a flight with this stock.
On November 28, 2023 - on this message board POST #79, I posted that I am selling my stock.
Since my sale at $2.69 the stock has gone down to .18 cents a share.
There are many reasons for the stock decline and I have posted those reasons on this message board numerous times.
This company is heading to 0001 a share and there is little that can be done because Ellery Roberts does not understand how the stock market works and what it takes for a stock to increase.
68% of Nasdaq companies get delisted within 5-years
62% of NYSE companies get delisted within 5-years
94% of OTC companies have a declining stock price every 12-months.
We see the righting on the wall and that means EFSH will be delisted very very soon and onto the OTC and we all know what that means.
As for insiders buying the stock, it hasn't helped and anyone that thinks it will help does not understand investing.
Ellery and his minions need to be bold and creative if they want to save their Nasdaq listing and see the stock increase.
Positive posts on a message board are just that - words with little to no meaning
Direct to consumer is a costly endeavor that would probably be in the $30-$50 customer acquisition cost when all is said and done. It would be great if Endonovo can start selling at amazon.com, but the product is not approved for such sales and distribution.
But that does not matter because the medical device has not been approved by the FDA for that type of sales and distribution. They have to go through a prescription.
I also question if the device has any viability. The reason I say that is because sales have been zero. The VA hospital, which is allowed to prescribe it to their patients has zero sales. Keep in mind the VA hospital has a large budget for medical devices to be used on their patients.
It's easy for the company or a paid representative to tell you how great the product is, or have a third party boast about the usage of a product, BUT SALES IS THE ONLY LEGITIMATE AND PROOF OF CONCEPT. Words and meaningless, sales have value above and beyond just money.
If the product is that good, as some have claimed, then I ask why is the FDA not allowing it to be sold directly to consumers?
Your wording in your post is eloquent, but I ask you - WHERE ARE THE SALES.
Words like 'showed promise' and 'device can be used to treat more than one type of injury' and 'fact this is in use at VA hospitals' are nice words, but WHERE ARE THE SALES.
Sales, whether it be Apple or Best Buy, all the way to all those pharmaceuticals and medical device companies, the only thing that matters is sales.
Everything else is conversation with no substantial meaning. It's pontificating.
I do not think any common sense person expects Endonovo to have Apple or Best Buy numbers, but when all the company has to show is $80 thousand in sales after raising $20 plus million, and an upside-down balance sheet that includes toxic financings and conversions to common stock that will bring ENDV to 0001 a share, maybe eloquent words and pontificating should be stopped.
Please don't tell me SALES ARE COMING.
Please don't tell me the Pandemic hurt Endonovo badly, because I can show you many medical device companies that have increased sales during and post pandemic.
Medical device companies took advantage of the money the US government was handing out to companies during the pandemic.
And I also think using the VA hospital is a bad example because endonovo has claimed to be serving the VA Hospitals for years, and yet sales are ??????
A valuation on paper means nothing. No investment fund is going to trust Alan Collier by making an investment into his company, companies or spin offs.
Investment firms conduct a great deal of due diligence and there are so many red marks on Alan Collier which means no real, sophisticated & investment firm will give him money.
Alan has never raised any money from investment firms while running Endonovo, and no one can ever say convertible notes are investments. They are toxic financings that are done with no due diligence and in most cases the funder never even meets the CEO because the CEO and the business are irrelavent. The only thing that matters to a convertible note investor is liquidity in the stock.
A public company that accepts convertible notes has always, and when I say always, I mean 100% of the time, seen the market cap go down. Never has there been a company that has had stock price appreciation after taking a convertible note.
Endonovo is that company now, and has been for many years, and the stock price shows that to be true.
As for valuation report, whomever Alan Collier is paying for this so-called valuation report will write whatever Alan wants written and it does nothing other than give him some sort of document that he can give to unsophisticated investors.
You should do your own due diligence by reading all SEC filings by EFSH. Making a decision based on my post is not the way to make investment decisions.
There have been a number of filings by EFSH regarding the Mast Hill convertible note, but here is one paragraph that shows a 20% discount to market:
The Note is convertible into common shares at the option of the Purchaser at any time on or following the date that an event of default (as defined in the Note) occurs under the Note at a conversion price equal the lower of (i) $4.20 (subject to adjustments) and (ii) 80% of the lowest volume weighted average price of the Company’s common shares on any trading day during the five (5) trading days prior to the conversion date; provided that such conversion price shall not be less than $0.03 (subject to adjustments).
Like any convertible notes, there are a number of stipulations and different discounts to market.
They also have warrants issued to Mast Hill which impact the share price or issuance of shares at a discount to market.
Bottom line is that everyone should do their own due diligence and read the SEC filings in their entirety, and under no circumstances take my wording and posts as being 100% accurate.
It must also be noted that EFSH did another capital raise this month. They issued a press release on July 14 and I do not know the terms of that deal so it would be important to get those details before making an investment decision.
In the last 10Q filed May 16 it shows EFSH has $24.8 million in convertible notes. I do not know all those details to repayment or issuance of shares and at what discounts to market price.
Why do you think the stock will go up?
Do you not know Mast Hill is receiving shares at a 35% discount to market. That is THIRTY PERCENT DISCOUNT TO MARKET. And they will continue to get that discount to market until total loan is paid off.
That means EFSH will continue to give Mast Hill shares at a discount to market for a very long time, because Mast Hill will never be given more that 4.99% of the outstanding shares at any one time.
What that really means is that if EFSH stock is 20 cents on Monday, EFSH will have to issue Mast Hill shares, up to 4.99% of the outstanding shares at 13 cents.
Mast Hill can sell shares into the market, and as long as they sell shares at or above 13 cents they make a profit. Then when those shares that they received are sold, and the price declines to lets say 13 cents, THEN EFSH HAS TO ISSUE MORE SHARES AT THE 35% DISCOUNT TO MARKET, WHICH IF EFSH IS 13 CENTS, THE DISCOUNT TO MARKET PRICE IS .085 cents a share.
Mast Hill will be given ADDITIONAL SHARES, up to 4.99% of the outstanding shares, at .085 a share, and they will see EFSH into the market and this will be a never ending process until EFSH gets to .0001, of they do a reverse split, which then the shares are issued at a 35% discount to market based on the higher stock price.
It's called a DEATH SPIRAL because it is a TOXIC FINANCING.
So I ask you one more time - why do you think EFSH stock will go up???
All that patent ownership yet they have zero sales.
Please don't tell me $87,540 in sales last quarter is sales. That number is embarrassing for a public company.
As for patents - meaningless unless you can make money.
You can own 100 patents, but if your not generating revenues then its meaningless.
Concrete company was a another sad business plan and strategy.
Putting aside Alan Collier's ineptness in the medical device business, his inability to raise a single penny from a legitimate investment, only dealing with toxic financiers, THEN HE DECIDES to go into the concrete business.
That move shows his expectations for PEMF & Sofpulse because No CEO of a medical device company, that believed in the medical devices that he is selling, would even entertain a concrete company, but Alan Collier knows that Sofpulse does not sell, because it has never sold, and for the reason he wanted to buy a concrete company, which he failed at doing.
Concrete company. Just think about that. Alan Collier wanted to buy a concrete company using ENDV investors money.
Here is the press release Alan Collier issued. Almost every line has misleading or inaccurate wording, starting with the headline where it was a DEFINITIVE AGREEMENT. How many other lies can you identify?
Endonovo Therapeutics Signs Definitive Asset Purchase Agreement to Acquire A Highly Profitable Texas Concrete Construction Company
Los Angeles, CA., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) and Western Star Concrete LLC, a highly profitable Texas concrete construction company located in the greater Dallas region, today announced the signing of a definitive purchase agreement for Endonovo to acquire all of Western Star’s assets and business operations.
The Agreement is a unique opportunity to greatly enhance Western Star’s position as a regional leader in the specialty concrete construction sector with multiple expansion opportunities generally throughout the Southeast region of the US. Presently, Western Star business generates revenue with net annual operating profits of $6.3 million.
“The acquisition of the Western Star assets and the opportunities to expand into other geographic regions in Texas present significant opportunities to significantly increase company net cash flows. The current profitability and future demonstrable growth provides a great value for Endonovo and our shareholders”, CEO Alan Collier said in making the announcement. “This opportunity will be accretive for Endonovo’s valuation from year one. There will be significant potential for synergies estimated, under normal operating conditions and generate between $30 million and $60 million in revenues per year according to three-year lookback financial reporting,” he said.
Collier also pointed out: “The new Endonovo construction entity formed will aim to continue to generate a Compound Annual Growth Rate (CAGR) of an estimated 15% to 20% annually. Ongoing business will be structured and expanded through the already successful Western Star management team that, as an example produced 52% growth from 2020 to 2021. Western Star financial performance has sustained a 15% to 20% CAGR over a three-year financial lookback in the specialized concrete construction sector. Our vision for Western Star’s business expansion would have broad geographical reach with present marketing plans to expand into multiple Texas cities in the next few years.”
I just read that Clearday is giving up their businesses. the CEO bragged about how he was going to make money with Memory Care and all the other senior living centers, but now he is walking away from the leases. According to some recent press releases he is going into the robotics business. But he doesn't have engineers or R&D and based on some really poorly written press releases it looks as if he will be a salesman for another company that is manufacturing robots.
Clearday does not own the technology or patents, and unless I am wrong, they are strictly a sales force.
The CEO failed 100% at the business, the balance sheet is a disaster, and they have those financing deals thata re high interest or convertible to stock at 50% discount to market. Has this guy ever turned a profit or is he in the business of losses and tax right offs. What an embarrassment.
And then some crazy deal with a nasdaq company that is or was a SPAC. Are the people at the SPAC out of their minds. What the heck is going on? has the entire world lost any sense of business 101, profitability or common sense business deals.
I will leave it off with this - I haven't looked at CLRD in a few months and I read the latest 10K and some press releases and maybe I am going crazy bit who in their right mind would want to give money to Clearday and the management team that has NEVER EVER turned a profit.
I do not know about charts and all those acronyms some of you self-proclaimed investing pros are talking about, but when a public company does a financing with Mast Hill, as is the case with EFSH, all those other companies stock value and market cap have gone down. 100%.
And the reason it is 100% is because Mast Hill does toxic financings, and for you self proclaimed experts, toxic financing is called toxic because shares are given at a 25% discount to market on a continuous basis until the convertible note is paid off, or the equity line is completed.
So all those charts and all that wishing, praying and hopeing is for nothing because toxic financings but charts to shame. That is why EFSH will be in the 0001 range soon, or at least soon after the delisting of the stock.
Read Post 32998
Anyone that is considering investing in ENDV or any public company for that matter should read the post by Biotech_Tradez post 32998.
That persons post shows how Endonovo has legally scammed people by having people buy shares of ENDV on the open market, yet very little money ever went into the business.
There is a reason over 62% of NYSE companies, 68% of Nasdaq companies get delisted within 5 years.
There is a reason 94.8% of OTC companies stock go down every year for the last 11 years.
There is a reason HEDGE FUNDS show the largest profit based on percentages compared to mutual funds, traditional investment funds. It's because Hedge Funds SHORT stock and it is much easier to predict a short than a long winner.
As for Endonovo - they have raised over $26 million and they have absolutely nothing to show for it. I do not know who and what type of person Alan Collier is, or what habits he has, but I am guessing he is living a nice life somewhere and that is a result of the money unsuspecting investors have invested into ENDV. His life might be nice right now, but I believe in KARMA and there will be some serious affliction that is bestowed upon him. Maybe he has had that affliction already, or maybe he is going through it right how, or it will be in the future whether on this earth or in his after-life, but as sure as my hair is turning gray, he will face reckoning day at some point.
If anyone plans on replying to this post by saying I am Biotech_Tradez and somehow spins it to their benefit by leading people to think I am 2 separate posters by having 2 investorhub ID's- GET A LIFE. I am NOT Biotech_Tradez, I just happen to agree with him 100% on Endonovo.
And if someone wants to believe I am Biotech_Tradez, then I ask you where has BioTech-Tradez posts or my posts been wrong?
As for replies - Alan Collier has pocketed a great deal of money and there are ZERO sales to show for it. If anyone tried to reply to Biotech_Tradez or this post, you are who you are and it is not worth my time to try to change your mind, or you are being compensated to be positive and refute any and all negative posts.
A real company would not need someone to refute negative posts.
A good CEO would earn money honestly and focus his efforts and money on the business and growing a business.
SAD what Alan Collier has gotten away with here.
He is mainly to blame, but a good portion of the blame should go onto the SEC for allowing misleading statements to be made through press releases & 8K filings. See Biotech_Tradez post which have a good amount of those misleading things, I am sure there is more.